Shared on27 Aug 25Fair value Decreased 3.45%
The reduction in ICU Medical’s price target reflects weaker growth expectations, as consensus revenue projections have turned negative, while a lower future P/E ratio suggests diminished earnings optimism; accordingly, the fair value estimate has decreased from $182.80 to $176.50. What's in the News ICU Medical raised its 2025 GAAP net loss guidance, now expecting a loss between $43 million and $35 million, with GAAP diluted loss per share between $1.68 and $1.38.